Maria Elena Maccari
Senior author studying primary immunodeficiencies and their treatment
Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center – University of Freiburg, Germany
Portrait: Faculty of Medicine, University of Freiburg (IMMediate programme)
Maria Elena Maccari works at the Institute for Immunodeficiency, Center for Chronic Immunodeficiency, at the University of Freiburg Medical Center, and in the pediatric hematology-oncology and stem cell transplantation division of Freiburg's Children's Hospital.
Senior author of a 2026 ESID registry-based analysis of 95 patients with Activated PI3-Kinase-δ Syndrome, comparing rapamycin against the newer targeted inhibitor leniolisib in real-world clinical practice.
Milestones in the Atlas
A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.
| Year | Evidence | Study |
|---|---|---|
| 2026 | H | Leniolisib and rapamycin in Activated PI3-Kinase-δ-syndrome: a retrospective ESID registry-based analysis RIV2026 Senior author: real-world ESID registry analysis of rapamycin vs. leniolisib in Activated PI3Kδ Syndrome. |
Co-authors in the Atlas 1
People with a profile here who share at least one study with Maria Elena Maccari.
ShowHide
- Beatrice Rivalta First author of a multicenter registry analysis comparing rapamycin and leniolisib in a rare immune disorder
Every researcher with a profile →
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.
Thank you. Your answer was counted anonymously.